AbMole| Romosozumab（CAS号: 909395-70-6）

Romosozumab是首款靶向Sclerostin的人源化IgG2单抗。Romosozumab 是一种人源化抗硬化蛋白单克隆抗体，可通过抑制骨吸收促进骨形成和抑制骨硬化素。Romosozumab 可用于骨质疏松的研究。

1.化学性质

CAS号	909395-70-6
储存条件	Please store the product under the recommended conditions in the Certificate of Analysis.
运输方式	冰袋运输，根据产品的不同，可能会有相应调整。

 

2.参考文献

[1] S Singh, et al. Osteoporos Int. A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis

[2] Julia Paik, et al. Drugs Aging. Romosozumab: A Review in Postmenopausal Osteoporosis

[3] Kenneth G Saag, et al. N Engl J Med. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

[4] Leonardo Bandeira, et al. Expert Opin Biol Ther. Romosozumab for the treatment of osteoporosis

[5] Felicia Cosman, et al. N Engl J Med. Romosozumab Treatment in Postmenopausal Women with Osteoporosis